Novo Nordisk just pulled off something nobody saw coming
Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
This article first appeared on GuruFocus. Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical…
FDA approves weight loss drug in daily pill form
FDA approves weight loss drug in daily pill form – CBS News Watch CBS News Regulators at the…
Employers drop obesity drug coverage as cash-pay programs grow
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop…
Popular weightloss drug Ozempic launched in India at the price of Rs…, check dosage, more details
Danish drugmaker Novo Nordisk launched its most popular weight-loss drug Ozempic in India on Friday. The price of…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
Denmark’s $600 Billion Economy Just Got a Boost–Thanks to One Drugmaker
This article first appeared on GuruFocus. Denmark just ripped up its old growth script and penciled in a…
Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National
Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans are not…
Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong…
U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs
The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening…